Atlas Trials

First Human Dose Trial of NNC0215-0384 in Subjects With Rheumatoid Arthritis

Clinical trial NCT01611688 · COMPLETED

Trial details

NCT number
NCT01611688
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
InflammationRheumatoid Arthritis
Start date
2012-06-04
Primary completion
2013-06-17
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.